Martin M. Kimani

FDA investigator

Appears on 4 documents from 2025 to 2026, mostly at sites in Ohio. Most often cites production record review (21 CFR 211.192).

4
Documents on file
5.5
Observations per 483
2025
First seen
2026
Most recent

What they cite most

From 22 observations

Activity by year

2025: 3, 2026: 1

Where

Ohio 2 · Georgia 1 · Indiana 1

Is Martin M. Kimani coming to your site?

Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.

Ask about any investigator in Claude or ChatGPT with the AI connector.

Inspection history

4 documents, newest first
FirmOpen
483 Newton Laboratories, Inc.Mar 26, 2026 · Conyers, Georgia
483 Smithfield Biosciences, IncDec 23, 2025 · Cincinnati, Ohio
483 Catalent Indiana LLCJul 14, 2025 · Bloomington, Indiana
483 KUTOL PRODUCTS COMPANYMar 4, 2025 · SHARONVILLE, Ohio

About this profile

What does Martin M. Kimani inspect?

Martin M. Kimani appears on 4 documents on file covering 4 sites, mostly in Ohio.

What do they cite most often?

21 CFR 211.192 (production record review), followed by 21 CFR 211.100 and 21 CFR 211.166.

Can I read the observations?

Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.

How current is this profile?

The most recent document on file for Martin M. Kimani is dated Mar 26, 2026.